Company Search:
Advanced Search
Sponsored Links
Agios Pharmaceuticals Inc Company Snapshot
Agios Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Agios Pharmaceuticals Inc with three other companies in this sector in the United States: CTI BioPharma Corp (2016 sales of $57.41 million of which 100% was License & Contract Revenues), Progenics Pharmaceuticals, Inc. ($69.43 million of which 100% was Biopharmaceutical), and Corcept Therapeutics Incorporated ($81.32 million of which 100% was Pharmaceutical Products).

Sales Analysis. During the year ended December of 2016, sales at Agios Pharmaceuticals Inc were $69.89 million. This is an increase of 18.2% versus 2015, when the company's sales were $59.12 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Agios Pharmaceuticals Inc
  Stock Performance Chart for Agios Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 53.66
(Figures in U.S. Dollars)
1 Week 2.7%   13 Weeks -0.8%  
4 Weeks 19.0%   52 Weeks 48.6%  
Agios Pharmaceuticals Inc Key Data:
  Ticker: AGIO Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 69,892,000
(Year Ending Jan 2017).
Employees: 287
  Currency: U.S. Dollars Market Cap: 2,266,293,397
  Fiscal Yr Ends: December Shares Outstanding: 42,234,316
  Share Type: Common Closely Held Shares: 989,689
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.